Wang, L.; Zhao, C.; Lu, L.; Jiang, H.; Wang, F.; Zhang, X.
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2023, 24, 4646.
https://doi.org/10.3390/ijms24054646
AMA Style
Wang L, Zhao C, Lu L, Jiang H, Wang F, Zhang X.
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2023; 24(5):4646.
https://doi.org/10.3390/ijms24054646
Chicago/Turabian Style
Wang, Longkun, Chunqian Zhao, Lu Lu, Honglei Jiang, Fengshan Wang, and Xinke Zhang.
2023. "Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer" International Journal of Molecular Sciences 24, no. 5: 4646.
https://doi.org/10.3390/ijms24054646
APA Style
Wang, L., Zhao, C., Lu, L., Jiang, H., Wang, F., & Zhang, X.
(2023). Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 24(5), 4646.
https://doi.org/10.3390/ijms24054646